» Articles » PMID: 33061754

The Association of Lipid Metabolism and Non-alcoholic Fatty Liver Disease in Children with Obesity

Overview
Publisher Kare Publishing
Specialty Pediatrics
Date 2020 Oct 16
PMID 33061754
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: Obesity, insulin resistance, and hyperlipidemia have been shown as risk factors for non-alcoholic fatty liver disease. In this study, the association between lipid and lipoprotein metabolism abnormalities and the presence of non-alcoholic fatty liver disease was investigated in patients with obesity.

Material And Methods: In this study, the clinical, laboratory and imaging findings of 357 children and adolescent patients (199 girls and 158 boys) aged 2-18 years who were diagnosed as having obesity between 2013 and 2018 were retrospectively analyzed. The clinical and laboratory features of the patients who were diagnosed as having non-alcoholic fatty liver disease using ultrasonography were compared with patients who did not have non-alcoholic fatty liver disease. All lipid and lipoprotein levels were defined as hypo-, normo- and hyperlipidemic in comparison with the reference values according to age and sex.

Results: The frequency of non-alcoholic fatty liver disease was 44.5% in the entire study group and was higher in males (p<0.05). The body weight, body mass index, alanine aminotransferase, glucose, insulin, non-high-density lipoprotein-cholesterol, and HOMA-IR scores were found to be higher in the patients with non-alcoholic fatty liver disease, whereas the high-density lipoprotein-cholesterol level was lower (p<0.05). There was no difference in the frequency of non-alcoholic fatty liver disease among the patients with low, normal, and high total cholesterol, triglyceride and low-density lipoprotein-cholesterol levels (p>0.05). The frequency of lipid metabolism disorder (hypolipidemia and/or hyperlipidemia) was found as 77.5% in all patients.

Conclusion: Non-alcoholic liver disease and lipid metabolism disorders are common in children and adolescents with obesity. The frequency of non-alcoholic fatty liver disease in hypolipidemic, normolipidemic, and hyperlipidemic patients was not different. This finding indicated that the increase in the amount of body fatty tissue and insulin resistance were more important risk factors in the development of non-alcoholic fatty liver disease.

Citing Articles

The Level of Inflammatory Markers and Their Relationship with Fat Tissue Distribution in Children with Obesity and Type 2 Diabetes Mellitus.

Akalin Erturk B, Gulbahar O, Kaymak Sahap S, Bulut T, Cetinkaya S, Savas Erdeve S Turk Arch Pediatr. 2023; 58(5):485-493.

PMID: 37553968 PMC: 10543068. DOI: 10.5152/TurkArchPediatr.2023.22288.


[A cross-sectional study on the prevalence rate and influencing factors of non-alcoholic fatty liver disease in overweight/obese children].

Dai W, Yao Z, Ou-Yang S, Xu N, Zhou H, Li X Zhongguo Dang Dai Er Ke Za Zhi. 2023; 25(5):448-456.

PMID: 37272169 PMC: 10247205. DOI: 10.7499/j.issn.1008-8830.2211018.


The lipid-lowering effects of fenugreek gum, hawthorn pectin, and burdock inulin.

Wang Y, Zheng Y, Liu Y, Shan G, Zhang B, Cai Q Front Nutr. 2023; 10:1149094.

PMID: 37032784 PMC: 10076561. DOI: 10.3389/fnut.2023.1149094.


Jinlida Granules Reduce Obesity in db/db Mice by Activating Beige Adipocytes.

Zhou H, Wang T, Hao Y, Hou Y, Wei C, Yao B Biomed Res Int. 2022; 2022:4483009.

PMID: 35647185 PMC: 9135524. DOI: 10.1155/2022/4483009.

References
1.
Hsiao P, Lee M, Wang Y, Jiang H, Lin P, Connie Yang Y . MTTP-297H polymorphism reduced serum cholesterol but increased risk of non-alcoholic fatty liver disease-a cross-sectional study. BMC Med Genet. 2015; 16:93. PMC: 4603340. DOI: 10.1186/s12881-015-0242-6. View

2.
Virani S . Non-HDL cholesterol as a metric of good quality of care: opportunities and challenges. Tex Heart Inst J. 2011; 38(2):160-2. PMC: 3066801. View

3.
Munoz Torres M, Cano Romera A, Dominguez S, Cano Parra M, Lobon J, Escobar Jimenez F . [Familial hypobetalipoproteinemia: description of a heterozygous form with important biochemical alterations]. Rev Clin Esp. 1991; 188(2):81-2. View

4.
Hagve T, Myrseth L, Schrumpf E, Blomhoff J, Christophersen B, Elgjo K . Liver steatosis in hypobetalipoproteinemia. A case report. J Hepatol. 1991; 13(1):104-11. DOI: 10.1016/0168-8278(91)90871-8. View

5.
Gokce S, Atbinici Z, Aycan Z, Cinar H, Zorlu P . The relationship between pediatric nonalcoholic fatty liver disease and cardiovascular risk factors and increased risk of atherosclerosis in obese children. Pediatr Cardiol. 2012; 34(2):308-15. DOI: 10.1007/s00246-012-0447-9. View